J. Bleesing

发表

Mg2+ Regulates Cytotoxic Functions of NK and CD8 T Cells in Chronic EBV Infection Through NKG2D

S. Pittaluga, M. Biancalana, T. Kuijpers, 2013, Science.

Complement blockade for TA-TMA: lessons learned from large pediatric cohort treated with eculizumab.

Ranjit S. Chima, Kana Mizuno, K. Myers, 2020, Blood.

Current Flow Cytometric Assays for the Screening and Diagnosis of Primary HLH

S. Chiang, R. Marsh, J. Bleesing, 2019, Front. Immunol..

Primary Immune Deficiency Treatment Consortium (PIDTC) report.

M. van der Burg, L. Notarangelo, H. Bobby Gaspar, 2014, The Journal of allergy and clinical immunology.

The Value of Chromosome Analysis to Interrogate Variants in DNMT3B Causing Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome Type I (ICF1)

T. Smolarek, Miao Sun, P. Rathbun, 2019, Journal of Clinical Immunology.

Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation.

S. Davies, P. Mehta, J. Goebel, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Functional Reprogramming of Regulatory T cells in the absence of Foxp3

P. Carmeliet, M. Pellegrini, T. Chatila, 2019, Nature Immunology.

Gimap5-dependent inactivation of GSK3β is required for CD4+ T cell homeostasis and prevention of immune pathology

J. Woodgett, Harinder Singh, David A Hildeman, 2018, Nature Communications.

Alternative donor SCT for the treatment of MHC Class II deficiency

W. Friedrich, P. Veys, R. Chiesa, 2013, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations.

Smita Y. Patel, R. Döffinger, J. Casanova, 2017, Blood.

Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy

K. Myers, S. Davies, S. Jodele, 2020, Journal of Clinical Immunology.

A rapid flow cytometric screening test for X‐linked lymphoproliferative disease due to XIAP deficiency

A. Snow, D. Marmer, H. Su, 2009, Cytometry. Part B, Clinical cytometry.

Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations.

D. Marmer, Mi‐Ok Kim, Kejian Zhang, 2009, Clinical immunology.

Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study

F. Rieux-Laucat, A. Schulz, H. Kanegane, 2017, The Journal of allergy and clinical immunology.

Persistent Enteropathy in a Toddler with a Novel FOXP3 Mutation and Normal FOXP3 Protein Expression.

Z. Kucuk, J. Bleesing, Sara P Seghezzo, 2017, The Journal of pediatrics.

A challenging undertaking: Stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.

S. Davies, Kejian Zhang, A. Filipovich, 2016, The Journal of allergy and clinical immunology.

T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome

S. Prahalad, E. Waller, C. Bennett, 2021, Blood.

Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab

A. Filipovich, J. Kanter, C. Allen, 2013, Pediatric blood & cancer.

A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.

A. Vinks, K. Myers, S. Davies, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disorders.

A. Filipovich, J. Villanueva, R. Marsh, 2011, Journal of immunological methods.

Defective FAS-mediated apoptosis and immune dysregulation in Gaucher disease.

M. Di Rocco, Federica Lanza, E. Cappelli, 2020, The journal of allergy and clinical immunology. In practice.

CTLA-4 haploinsufficiency in a patient with an autoimmune lymphoproliferative disorder.

T. Chatila, R. Mcmasters, L. Charbonnier, 2017, The Journal of allergy and clinical immunology.

Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology.

Kathleen C. Williams, J. Orange, P. Yong, 2010, Clinical immunology.

Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes.

A. Fischer, H. Kanegane, P. Veys, 2013, Blood.

Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.

A. Filipovich, R. Marsh, J. Bleesing, 2010, Journal of immunological methods.

Outcome of hematopoietic cell transplantation for DNA double‐strand break repair disorders

A. Fischer, A. Schulz, A. Gennery, 2018, The Journal of allergy and clinical immunology.

Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen

S. Davies, P. Mehta, S. Jodele, 2008, Bone Marrow Transplantation.

A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in mice

Erica G. Schmitt, J. Edwards, A. Thatayatikom, 2022, JCI insight.

Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation

S. Davies, M. Jordan, Ashish R. Kumar, 2020, Journal of Clinical Immunology.

Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation

S. Davies, M. Jordan, Ashish R. Kumar, 2020, Journal of clinical immunology.

Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.

S. Davies, P. Mehta, Mi‐Ok Kim, 2010, Blood.

Flow cytometric measurement of SLAM-associated protein and X-linked inhibitor of apoptosis.

A. Filipovich, R. Marsh, J. Bleesing, 2013, Methods in molecular biology.

Analyses of the PRF1 Gene in Individuals with Hemophagocytic Lymphohystiocytosis Reveal the Common Haplotype R54C/A91V in Colombian Unrelated Families Associated with Late Onset Disease

J. Franco, J. Zimmer, C. Trujillo-Vargas, 2012, Journal of Clinical Immunology.

STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America

N. Satake, Kejian Zhang, A. Filipovich, 2010, Pediatric blood & cancer.

Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.

A. Vinks, S. Davies, P. Mehta, 2010, Biology of Blood and Marrow Transplantation.

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

Christopher Baum, David A. Williams, Gregory Hopkins, 2014, The New England journal of medicine.

Post-Transplant CD34+ Selected Stem Cell "Boost" for Mixed Chimerism after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Children and Young Adults with Primary Immune Deficiencies.

S. Davies, M. Jordan, P. Khandelwal, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cutaneous infection with Metarhizium anisopliae in a patient with hypohidrotic ectodermal dysplasia and immune deficiency.

David A. Williams, J. Casanova, A. Puel, 2008, The Pediatric infectious disease journal.

Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome.

J. Bernstein, H. Saal, R. Hopkin, 2016, The Journal of allergy and clinical immunology.

Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH.

S. Choo, Kejian Zhang, A. Lane, 2017, Blood.

Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1.

S. Davies, A. Filipovich, M. Jordan, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT

J. Khoury, S. Davies, P. Mehta, 2011, Bone Marrow Transplantation.

An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.

K. Myers, S. Davies, P. Mehta, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Emerging Targets for Hematopoietic Cell Transplantation (HCT): Genetic Disorders of Hematopoiesis and Immunity

A. Filipovich, F. Goldman, J. Bleesing, 2007 .

Human Papillomavirus Oral- and Sero- Positivity in Fanconi Anemia

K. Myers, S. Davies, P. Mehta, 2021, Cancers.

IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome.

David A Hildeman, A. Sholl, J. Bleesing, 2015, The Journal of allergy and clinical immunology.

Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation.

S. Davies, M. Jordan, Ashish R. Kumar, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Elevated Granzyme B in Cytotoxic Lymphocytes is a Signature of Immune Activation in Hemophagocytic Lymphohistiocytosis

Kejian Zhang, A. Filipovich, J. Villanueva, 2013, Front. Immunol..

Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.

J. Khoury, K. Myers, S. Davies, 2014, Blood.

Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT

L. Notarangelo, J. Puck, T. Torgerson, 2019, Journal of Clinical Immunology.

Outcome of patients with NEMO deficiency following allogeneic hematopoietic cell transplant.

S. Holland, G. Uzel, K. Shah, 2017, The Journal of allergy and clinical immunology.

Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency.

L. Notarangelo, J. Walter, R. Geha, 2019, The journal of allergy and clinical immunology. In practice.

Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen.

K. Myers, S. Davies, P. Mehta, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of donor lymphocyte infusion for treatment of mixed donor chimerism after a reduced-intensity preparative regimen for pediatric patients with nonmalignant diseases.

S. Davies, A. Filipovich, M. Jordan, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful early intervention for hyperacute transplant‐associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation

P. Mehta, J. Goebel, S. Jodele, 2012, Pediatric transplantation.

Outcomes following hematopoietic cell transplantation for Wiskott–Aldrich syndrome

S. Davies, P. Mehta, S. Jodele, 2012, Bone Marrow Transplantation.

Thrombotic Microangiopathy Can Occur Before Transplant in Children with HLH

S. Davies, S. Jodele, M. Jordan, 2017 .

Prevalence of Viral Infections in Children Undergoing First Allogenic Hematopoietic Stem Cell Transplantation: Two Year Single Center Experience

K. Myers, S. Davies, P. Mehta, 2012 .

Complement Blockade for TA-TMA: Lessons Learned from Large Pediatric Cohort Treated with Eculizumab

Kana Mizuno, K. Myers, S. Davies, 2020 .

Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)

A. Vinks, Kana Mizuno, K. Myers, 2015 .